Surface-Exposed Protein Moieties of Burkholderia cenocepacia J2315 in Microaerophilic and Aerobic Conditions
- PMID: 38675780
- PMCID: PMC11054960
- DOI: 10.3390/vaccines12040398
Surface-Exposed Protein Moieties of Burkholderia cenocepacia J2315 in Microaerophilic and Aerobic Conditions
Abstract
Burkholderia cepacia complex infections remain life-threatening to cystic fibrosis patients, and due to the limited eradication efficiency of current treatments, novel antimicrobial therapies are urgently needed. Surface proteins are among the best targets to develop new therapeutic strategies since they are exposed to the host's immune system. A surface-shaving approach was performed using Burkholderia cenocepacia J2315 to quantitatively compare the relative abundance of surface-exposed proteins (SEPs) expressed by the bacterium when grown under aerobic and microaerophilic conditions. After trypsin incubation of live bacteria and identification of resulting peptides by liquid chromatography coupled with mass spectrometry, a total of 461 proteins with ≥2 unique peptides were identified. Bioinformatics analyses revealed a total of 53 proteins predicted as localized at the outer membrane (OM) or extracellularly (E). Additionally, 37 proteins were predicted as moonlight proteins with OM or E secondary localization. B-cell linear epitope bioinformatics analysis of the proteins predicted to be OM and E-localized revealed 71 SEP moieties with predicted immunogenic epitopes. The protegenicity higher scores of proteins BCAM2761, BCAS0104, BCAL0151, and BCAL0849 point out these proteins as the best antigens for vaccine development. Additionally, 10 of the OM proteins also presented a high probability of playing important roles in adhesion to host cells, making them potential targets for passive immunotherapeutic approaches. The immunoreactivity of three of the OM proteins identified was experimentally demonstrated using serum samples from cystic fibrosis patients, validating our strategy for identifying immunoreactive moieties from surface-exposed proteins of potential interest for future immunotherapies development.
Keywords: Burkholderia cenocepacia; aerobic conditions; cystic fibrosis; microaerophilic conditions; surfomics.
Conflict of interest statement
The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11054960/bin/vaccines-12-00398-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11054960/bin/vaccines-12-00398-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11054960/bin/vaccines-12-00398-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11054960/bin/vaccines-12-00398-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11054960/bin/vaccines-12-00398-g005.gif)
Similar articles
-
Characterization of the Burkholderia cenocepacia J2315 Surface-Exposed Immunoproteome.Vaccines (Basel). 2020 Sep 6;8(3):509. doi: 10.3390/vaccines8030509. Vaccines (Basel). 2020. PMID: 32899969 Free PMC article.
-
New insights into the immunoproteome of B. cenocepacia J2315 using serum samples from cystic fibrosis patients.N Biotechnol. 2020 Jan 25;54:62-70. doi: 10.1016/j.nbt.2019.08.006. Epub 2019 Aug 26. N Biotechnol. 2020. PMID: 31465856
-
Comparative Genomics and Evolutionary Analysis of RNA-Binding Proteins of Burkholderia cenocepacia J2315 and Other Members of the B. cepacia Complex.Genes (Basel). 2020 Feb 21;11(2):231. doi: 10.3390/genes11020231. Genes (Basel). 2020. PMID: 32098200 Free PMC article.
-
Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium.Appl Microbiol Biotechnol. 2011 Dec;92(5):887-95. doi: 10.1007/s00253-011-3616-5. Epub 2011 Oct 14. Appl Microbiol Biotechnol. 2011. PMID: 21997606 Review.
-
Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.Clin Microbiol Infect. 2010 Jul;16(7):821-30. doi: 10.1111/j.1469-0691.2010.03237.x. Clin Microbiol Infect. 2010. PMID: 20880411 Review.
References
-
- Velez L.S., Aburjaile F.F., Farias A.R.G., Baia A.D.B., Oliveira W.J., Silva A.M.F., Benko-Iseppon A.M., Azevedo V., Brenig B., Ham J.H., et al. Burkholderia semiarida Sp. Nov. and Burkholderia sola Sp. Nov., Two Novel B. cepacia Complex Species Causing Onion Sour Skin. Syst. Appl. Microbiol. 2023;46:126415. doi: 10.1016/j.syapm.2023.126415. - DOI - PubMed
-
- Zolin A., Orenti A., Jung A., van Rens J., Prasad V., Fox A., Krasnyk M., Mayor S.L., Naehrlich L., Gkolia P., et al. ECFSPR Annual Report 2021. European Cystic Fibrosis Society; Karup, Denmark: 2023.
Grants and funding
LinkOut - more resources
Full Text Sources